Press releases View full list

September 11, 2018

Invitae Appoints Chitra Nayak to its Board of Directors

-- Bringing invaluable expertise in scaling transformative businesses throughout her career as a technology industry veteran --

SAN FRANCISCO, Sept. 11, 2018 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), one of the fastest growing genetics companies, announced the appointment of Chitra Nayak to its Board of Directors, effective September 10, 2018.

"We are pleased to welcome Chitra Nayak to our board of directors and look forward to working with her, taking full advantage of her considerable track record of helping companies achieve transformational growth to scale and innovate globally," said Sean George, co-founder and chief executive officer of Invitae. "Chitra has deep operational and commercial leadership expertise in growing market share and strengthening industry leadership positions for rapidly growing companies, including organizations like ours that are transforming highly competitive industries. Her strong customer orientation and perspective will be a valuable addition to our board as we scale our business to bring genetic information into mainstream medical care."

Nayak's depth of knowledge in sales leadership, operations and product management was built during a variety of leadership roles with fast-growing organizations such as, which grew from $300 million in revenue and 1,000 employees to $5 billion in revenue and 18,000 employees in the time she was with the company.

"Invitae's focus on making medical genetics affordable and accessible has the potential to transform healthcare. The company is driving the emergence of a new industry, moving from the test-by-test approach of the past to the creation of a network that will allow patients to receive a faster diagnosis and better treatment because they have access to information about their genes," said Nayak. "I'm happy to join the board at this exciting time and look forward to helping the team deliver on its mission to help improve healthcare for billions of people."

Nayak has more than 25 years of professional experience in product management, sales leadership, general management and operations roles at various companies, having successfully built operational engines to enable these businesses to scale. Most recently she was COO running GTM at Comfy, Inc., a disruptive real-estate tech startup revolutionizing the way people interact with their workplaces. Prior to joining Comfy in 2017, Nayak served as chief operating officer of Funding Circle LTD from 2015 to 2016. From 2007 to 2015, Nayak served in several positions at, Inc., including vice president of marketing strategy and operations from 2007 to 2008, senior vice president of global sales development from 2008 to 2013, and chief operating officer of platform from 2013 to 2015.

Nayak holds an M.B.A in Business Administration from Harvard Business School, an M.S. in Environmental Engineering from Cornell University, and a B.S. in engineering from Indian Institute of Technology.

About Invitae

Invitae Corporation (NYSE: NVTA) is a genetics company whose mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. Invitae's goal is to aggregate most of the world's genetic tests into a single service with higher quality, faster turnaround time and lower prices.

Laura D'Angelo
(628) 213-3283


Cision View original content to download multimedia:

SOURCE Invitae Corporation

Investor Toolkit

Feature Presentation

Email Alerts

Sign up to receive Invitae financial information by email.
Email Address: *

Enter the code shown above.

Investor Contact

1400 16th St.
San Francisco, CA, 94103